Warning: The NCBI web site requires JavaScript to function. more...
AAV-mediated gene therapy for metabolic diseases: dosage and reapplication studies in the molybdenum cofactor deficiency model.
Hahnewald R, Wegner W, Reiss J.
Genet Vaccines Ther. 2009 Jun 18;7:9.
Related citations
Long-term rescue of a lethal inherited disease by adeno-associated virus-mediated gene transfer in a mouse model of molybdenum-cofactor deficiency.
Kügler S, Hahnewald R, Garrido M, Reiss J.
Am J Hum Genet. 2007 Feb;80(2):291-7. Epub 2006 Dec 19.
Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing.
Ulrich-Vinther M.
Acta Orthop Suppl. 2007 Apr;78(325):1-64. Review.
Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors.
Yan Z, Zak R, Luxton GW, Ritchie TC, Bantel-Schaal U, Engelhardt JF.
J Virol. 2002 Mar;76(5):2043-53.
Enhanced gene transfer efficiency in the murine striatum and an orthotopic glioblastoma tumor model, using AAV-7- and AAV-8-pseudotyped vectors.
Harding TC, Dickinson PJ, Roberts BN, Yendluri S, Gonzalez-Edick M, Lecouteur RA, Jooss KU.
Hum Gene Ther. 2006 Aug;17(8):807-20.
Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.
Li Q, Miller R, Han PY, Pang J, Dinculescu A, Chiodo V, Hauswirth WW.
Mol Vis. 2008 Sep 24;14:1760-9.
Genomic stability of self-complementary adeno-associated virus 2 during early stages of transduction in mouse muscle in vivo.
Ren C, Kumar S, Shaw DR, Ponnazhagan S.
Hum Gene Ther. 2005 Sep;16(9):1047-57.
Adeno-associated virus (AAV) capsid genes isolated from rat and mouse liver genomic DNA define two new AAV species distantly related to AAV-5.
Lochrie MA, Tatsuno GP, Arbetman AE, Jones K, Pater C, Smith PH, McDonnell JW, Zhou SZ, Kachi S, Kachi M, Campochiaro PA, Pierce GF, Colosi P.
Virology. 2006 Sep 15;353(1):68-82. Epub 2006 Jun 30.
Marker rescue of adeno-associated virus (AAV) capsid mutants: a novel approach for chimeric AAV production.
Bowles DE, Rabinowitz JE, Samulski RJ.
J Virol. 2003 Jan;77(1):423-32.
Enhancement of muscle gene delivery with pseudotyped adeno-associated virus type 5 correlates with myoblast differentiation.
Duan D, Yan Z, Yue Y, Ding W, Engelhardt JF.
J Virol. 2001 Aug;75(16):7662-71.
Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models.
Davidoff AM, Gray JT, Ng CY, Zhang Y, Zhou J, Spence Y, Bakar Y, Nathwani AC.
Mol Ther. 2005 Jun;11(6):875-88.
Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration.
Brockstedt DG, Podsakoff GM, Fong L, Kurtzman G, Mueller-Ruchholtz W, Engleman EG.
Clin Immunol. 1999 Jul;92(1):67-75.
AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect.
Su H, Huang Y, Takagawa J, Barcena A, Arakawa-Hoyt J, Ye J, Grossman W, Kan YW.
Gene Ther. 2006 Nov;13(21):1495-502. Epub 2006 Jun 15.
Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV.
Fan PD, Dong JY.
Hum Gene Ther. 1997 Jan 1;8(1):87-98.
Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors.
Manning WC, Zhou S, Bland MP, Escobedo JA, Dwarki V.
Hum Gene Ther. 1998 Mar 1;9(4):477-85.
Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2.
Grimm D, Kern A, Pawlita M, Ferrari F, Samulski R, Kleinschmidt J.
Gene Ther. 1999 Jul;6(7):1322-30.
Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
Aldrich WA, Ren C, White AF, Zhou SZ, Kumar S, Jenkins CB, Shaw DR, Strong TV, Triozzi PL, Ponnazhagan S.
Gene Ther. 2006 Jan;13(1):29-39.
Novel tools for production and purification of recombinant adenoassociated virus vectors.
Grimm D, Kern A, Rittner K, Kleinschmidt JA.
Hum Gene Ther. 1998 Dec 10;9(18):2745-60.
Long-term gene transfer to mouse fetuses with recombinant adenovirus and adeno-associated virus (AAV) vectors.
Mitchell M, Jerebtsova M, Batshaw ML, Newman K, Ye X.
Gene Ther. 2000 Dec;7(23):1986-92.
Postsurgical assessment and long-term safety of recombinant adeno-associated virus-mediated gene transfer into the retinas of dogs and primates.
Le Meur G, Weber M, Péréon Y, Mendes-Madeira A, Nivard D, Deschamps JY, Moullier P, Rolling F.
Arch Ophthalmol. 2005 Apr;123(4):500-6.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on